-
1 month ago | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A study published in Nature Communications investigated the use of Lynparza (olaparib) in patients with early-stage breast cancer who have inherited BRCA1 or BRCA2 gene mutations.
-
1 month ago | 
cancertodaymag.org | Marci Landsmann
APPROXIMATELY 40% of people with cancer who receive immune checkpoint inhibitors will experience immune-related adverse events (irAEs), ranging from mild symptoms of fatigue and rash to life-threatening conditions that can lead to hospitalizations and even death.
-
2 months ago | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Most adolescents and young adults (AYAs) with advanced cancer do not have discussions with health care providers about their goals for cancer treatment until the final month of life, according to a National Cancer Institute (NCI)-funded study published last year in JAMA Network Open.
-
Mar 21, 2025 | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Chemotherapy-induced peripheral neuropathy, characterized by numbness, pain and tingling in the hands and feet, can linger long after chemotherapy treatment is completed.
-
Feb 21, 2025 | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A recent study found that men who have metastatic hormone-sensitive prostate cancer often aren’t getting guideline-recommended care.
-
Jan 24, 2025 | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Two studies published in the British Journal of Sports Medicine add muscle to current exercise recommendations for cancer survival and prevention, according to a Guardian article published this week.
-
Nov 8, 2024 | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Timing seems to matter for palliative care’s ability to curtail aggressive and unnecessary ovarian cancer treatment for patients at the end of life. A study published Oct.
-
Oct 18, 2024 | 
cancertodaymag.org | Marci Landsmann
Results from a phase III clinical trial are likely to change treatment for newly diagnosed adolescents and adults with advanced-stage classic Hodgkin lymphoma (cHL). The study, published this week in the New England Journal of Medicine, included almost 1,000 patients with newly diagnosed stage III and IV lymphoma at more than 200 cancer centers in the U.S. and Canada.
-
Sep 20, 2024 | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. In many ways, the news is good: Between 1991 and 2021, cancer-related deaths in the U.S. decreased by 33%. New treatments, including immunotherapy and targeted treatments, are helping to extend the lives of many people with cancer.
-
Aug 16, 2024 | 
cancertodaymag.org | Marci Landsmann
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Even light drinking is associated with an increased risk of cancer death, a story published Aug. 12, 2024, in the New York Times reports. The article describes findings from a study that tracked more than 135,000 adults who were 60 years or older over 12 years.
